This is a randomized controlled trial comparing the mean and standard deviation of postobturation pain using two different sealers: a tricalcium silicate-based sealer (CeraSeal) and a resin-based sealer (Endoplus) in patients with symptomatic irreversible pulpitis undergoing root canal treatment.
• Patients of age group 18 to 60 years
Healthy patients with ASA class 1 and 2
Patients of both genders
Teeth diagnosed as symptomatic irreversible pulpitis
Teeth with calcified or previously treated canals
Immunocompromised or mentally handicapped patients
Pregnant or lactating mothers
Teeth with periodontal probing depths of 5 mm or more
Parallel
Tricalcium silicate sealar
DrugCeraseal (bioceramic sealer) - assigned to Group 2
Resin based sealer
DrugEndoplus (resin-based sealer) - assigned to Group 1
Postoperative pain after root canal treatment assessed using a Visual Analogue Scale (VAS)
Postoperative pain will be recorded using a 10-centimeter Visual Analogue Scale (VAS). On this scale, 0 indicates no pain and 10 indicates the worst pain imaginable. Higher scores correspond to greater pain intensity, meaning more pain. Patients will self-report their pain level at each time point (24 hours, 72 hours, and 7 days). This measure will be used to compare postoperative pain between patients treated with Endoplus resin-based sealer and CeraSeal bioceramic sealer.
Click on the lead sponsor to view all of their trials.
